{{Rsnum
|rsid=2076600
|Gene=ATP13A2
|Chromosome=1
|position=17010896
|Orientation=minus
|GMAF=0.3875
|Gene_s=ATP13A2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 62.8 | 35.4 | 1.8
| HCB | 19.7 | 50.4 | 29.9
| JPT | 17.7 | 56.6 | 25.7
| YRI | 32.9 | 50.0 | 17.1
| ASW | 35.1 | 52.6 | 12.3
| CHB | 19.7 | 50.4 | 29.9
| CHD | 40.4 | 34.9 | 24.8
| GIH | 44.6 | 46.5 | 8.9
| LWK | 42.7 | 45.5 | 11.8
| MEX | 34.5 | 43.1 | 22.4
| MKK | 14.1 | 51.3 | 34.6
| TSI | 54.9 | 38.2 | 6.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=22285144
|Title=ATP13A2 (PARK9) polymorphisms influence the neurotoxic effects of manganese
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}